CIK 0001382101 · Non-accelerated filer<br>Smaller reporting company
SUTRO BIOPHARMA, INC.
Sign in to watch- Ticker
- STRO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 452441988
- Phone
- 650-392-8412
- Business address
- 111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
- Former names
- SUTRO BIOPHARMA INC, Fundamental Applied Biology Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-01 | Chung Jane PRESIDENT AND COO | Shares withheld for taxes | −8,920 | $2.69 | $24K | 70,342 |
| 2024-12-01 | Chung Jane PRESIDENT AND COO | Option exercise · Restricted Stock Unit (RSU) | −25,000 | 75,000 | ||
| 2024-09-18 | Gerber Hans-Peter CHIEF SCIENTIFIC OFFICER | Option exercise | +37,500 | 37,500 | ||
| 2024-09-18 | Gerber Hans-Peter CHIEF SCIENTIFIC OFFICER | Shares withheld for taxes | −13,380 | $3.95 | $53K | 24,120 |
| 2024-09-18 | Gerber Hans-Peter CHIEF SCIENTIFIC OFFICER | Option exercise · Restricted Stock Units (RSUs) | −37,500 | 112,500 | ||
| 2024-08-09 | Chung Jane PRESIDENT AND COO | Option exercise | +18,750 | 60,951 | ||
| 2024-08-09 | Chung Jane PRESIDENT AND COO | Shares withheld for taxes | −6,689 | $3.12 | $21K | 54,262 |
| 2024-08-09 | Chung Jane PRESIDENT AND COO | Option exercise · Restricted Stock Unit (RSU) | −18,750 | 18,750 | ||
| 2024-08-08 | Jagpal Sukhi Director | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2024-08-08 | Jagpal Sukhi Director | Grant or award · Stock Option (Right to Buy) | +28,959 | 28,959 | ||
| 2024-07-08 | Leyman Barbara Chief Business Dev. Officer | Grant or award · Stock Option (Right to Buy Common Stock) | +125,000 | 125,000 | ||
| 2024-07-08 | Leyman Barbara Chief Business Dev. Officer | Grant or award · Restricted Stock Units (RSUs) | +100,000 | 100,000 | ||
| 2024-06-06 | Wigginton Jon Marc Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2024-06-06 | Petree Daniel H Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2024-06-06 | PANEK JAMES P Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2024-06-06 | MATSUI CONNIE Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2024-06-06 | Lobacki Joseph M Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2024-06-06 | Hunter Heidi Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2024-06-06 | Freund John Gordon Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2024-06-06 | Dybbs Michael Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 |
Page 10 of 13 · 252 trades